Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 1.00 |
| ▸ | POLB | P06746 | 1/20 | 1.00 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.84 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.72 |
| ▸ | CYP2C8 | P10632 | 4/20 | 0.72 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.72 |
| ▸ | CYP2B6 | P20813 | 4/20 | 0.72 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.72 |
| ▸ | LTA4H | P09960 | 3/20 | 0.72 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.72 |
| ▸ | HTR1A | P08908 | 2/20 | 0.71 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.71 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.71 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.71 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.67 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.61 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.57 |
| ▸ | ATM | Q13315 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28766005 | 1.00 | GAA (1.00) | GAAPOLBTRPV1CYP3A4CYP2C8 | |
| SCHEMBL29908853 | 1.00 | GAA (1.00) | GAAPOLBTRPV1CYP3A4CYP2C8 | |
| Hexahydrocurcumin SCHEMBL21187516 | 0.94 | POLB (0.88) | GAAPOLBTRPV1CYP3A4CYP2C8 | |
| Hexahydrocurcumin SCHEMBL29841863 | 0.94 | POLB (0.88) | GAAPOLBTRPV1CYP3A4CYP2C8 | |
| Hexahydrocurcumin SCHEMBL290121 | 0.94 | POLB (0.88) | GAAPOLBTRPV1CYP3A4CYP2C8 | |
| SCHEMBL10848972 | 0.92 | POLB (0.86) | GAAPOLBTRPV1CYP3A4CYP2C8 | |
| SCHEMBL10860098 | 0.92 | POLB (0.84) | GAAPOLBTRPV1CYP3A4CYP2C8 | |
| SCHEMBL23229890 | 0.92 | POLB (0.85) | GAAPOLBTRPV1CYP3A4CYP2C8 | |
| SCHEMBL22417772 | 0.91 | GAA (0.83) | GAAPOLBTRPV1CYP3A4CYP2C8 | |
| SCHEMBL25512250 | 0.90 | POLB (0.82) | GAAPOLBTRPV1CYP3A4CYP2C8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114533711-B | Application of diphenyl heptanone compounds in preparation of drugs for improving lipid metabolism and preparation method of compounds | 海南医学院 | 2024-01-30 | — | — | CN | claimed |
| CN-110236997-B | Composition with whitening effect and preparation method thereof | 佛山市普达美生物医药科技有限公司 | 2022-06-21 | — | — | CN | claimed |
| CN-112898143-A | 5-hydroxy-7- (4-hydroxy-3-methoxyphenyl) 1-phenyl-3-heptanone separated from galangal and application thereof | 海南医学院 | 2021-06-04 | — | — | CN | claimed |
| CN-114533711-B | Application of diphenyl heptanone compounds in preparation of drugs for improving lipid metabolism and preparation method of compounds | 海南医学院 | 2024-01-30 | — | — | CN | disclosed |
| CN-114533711-B | Application of diphenyl heptanone compounds in preparation of drugs for improving lipid metabolism and preparation method of compounds | 海南医学院 | 2024-01-30 | — | — | CN | disclosed |
| US-11540539-B2 | Reduced sodium food products | GENERAL MILLS, INC. (US) | 2023-01-03 | — | — | US | disclosed |
| EP-3732994-B1 | REDUCED SODIUM FOOD PRODUCTS | GEN MILLS INC (US) | 2022-11-09 | — | — | EP | disclosed |
| CN-110236997-B | Composition with whitening effect and preparation method thereof | 佛山市普达美生物医药科技有限公司 | 2022-06-21 | — | — | CN | disclosed |
| CN-110236997-B | Composition with whitening effect and preparation method thereof | 佛山市普达美生物医药科技有限公司 | 2022-06-21 | — | — | CN | disclosed |
| CN-112898143-A | 5-hydroxy-7- (4-hydroxy-3-methoxyphenyl) 1-phenyl-3-heptanone separated from galangal and application thereof | 海南医学院 | 2021-06-04 | — | — | CN | disclosed |
| CN-112898143-A | 5-hydroxy-7- (4-hydroxy-3-methoxyphenyl) 1-phenyl-3-heptanone separated from galangal and application thereof | 海南医学院 | 2021-06-04 | — | — | CN | disclosed |
| US-20150374021-A1 | REDUCED SODIUM FOOD PRODUCTS | GENERAL MILLS, INC. | 2015-12-31 | — | — | US | disclosed |
| US-20150374021-A1 | REDUCED SODIUM FOOD PRODUCTS | GENERAL MILLS, INC. | 2015-12-31 | — | — | US | disclosed |
| US-20150342233-A1 | REDUCED SODIUM FOOD PRODUCTS | GEN MILLS INC (US) | 2015-12-03 | — | — | US | disclosed |
| US-20150342233-A1 | REDUCED SODIUM FOOD PRODUCTS | GEN MILLS INC (US) | 2015-12-03 | — | — | US | disclosed |
| CN-101461526-B | Health product with liver-protecting and sobering-up functions and preparation method thereof | CHENGDU RUNXINTANG PHARMACEUTICAL CO., LTD. (CN) | 2011-12-28 | — | — | CN | disclosed |
| JP-2011001386-A | ADIPONECTIN PRODUCTION ENHANCER | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE & TECHNOLOGY | 2011-01-06 | — | — | JP | disclosed |
| CN-101461526-A | Health product with liver-protecting and sobering-up functions and preparation method thereof | CHENGDU RUNXINTANG PHARMACEUTI (CN) | 2009-06-24 | — | — | CN | disclosed |
| JP-2006045210-A | ADIPONECTIN PRODUCTION ENHANCER | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL & TECHNOLOGY | 2006-02-16 | — | — | JP | disclosed |
| US-20050215635-A1 | Diarylheptanoid compounds and uses thereof | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2005-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050215635-A1 | Diarylheptanoid compounds and uses thereof | CRH, HSD11B1, CYP46A1 | GAA 2467/4885POLB 4827/4885TRPV1 265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.